Picks for 1/10/2022

SDPI - Price has been consolidating for about a month and the MACD recently crossed. We also see a double bottom in December. With the price closing above the .23 fib level and the DI+ crossing the DI-on the ADX in recent days It looks like a bullish reversal is in coming.

Targeting: .9055, .9819, 1. 05in the short term.

RVPH - Food and Drug Administration (FDA) has notified the Company that it may proceed with Phase 3 clinical investigation of its lead candidate, brilaroxazine, a novel serotonin and dopamine receptor modulator for the treatment of schizophrenia.

Also watching: T, NLST, HALL, LTRX, IEP

8 views0 comments

Recent Posts

See All

PYPL - The 8/3 gap was filled on 2/1 at 89.63 and tested again. The most recent candles have been relatively large and green closing above the .5 fibonacci level. The 9 EMA crossed the 20 EMA shows

AES - AES made a "golden cross" on 9/1 and the daily candle made a bullish engulfing candle. In addition the Bullish Engulfing candle closed above the (weekly) descending trend line of the triangle. O

DCPH - Price is working its way to the end of the wedge and closed above the 1.61 fib level after pulling back from a bull flag . OBV crossed its 20 day EMA , D+ crossed D- on the ADX and the MAC